(Q30251866)

English

Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 June 2017

Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 June 2017

electronic health records

1 reference

based on heuristic

inferred from title

author name string

K J Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

13 June 2017

S Schneeweiss

2

1 reference

Europe PubMed Central

PubMed publication ID

13 June 2017

language of work or name

0 references

publication date

25 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

13 June 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

13 June 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

13 June 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 June 2017

147-159

1 reference

Europe PubMed Central

PubMed publication ID

13 June 2017

Why we need observational studies to evaluate the effectiveness of health care

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Representation of the elderly, women, and minorities in heart failure clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Use of health care databases in pharmacoepidemiology

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada: anti-viral drugs as an example

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Safety of Fixed Dose of Antihypertensive Drug Combinations Compared to (Single Pill) Free-Combinations: A Nested Matched Case-Control Analysis

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Effects of expiring reimbursability of pentaerythrityl tetranitrate (PETN, pentalong®) on anti-anginal therapy: an observational study.

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

The validity of medicaid pharmacy claims for estimating drug use among elderly nursing home residents: The Oregon experience

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Taking advantage of continuity of care documents to populate a research repository

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

The general practice research database: role in pharmacovigilance

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Compliance after switching from branded to generic statins

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Differing effects of metformin on glycemic control by race-ethnicity

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Initiation of oral contraceptives and changes in blood pressure and body mass index in healthy adolescents.

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

The effect of initiating pharmacologic insulin on serum uric acid levels in patients with diabetes: a matched cohort analysis

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

A review of uses of health care utilization databases for epidemiologic research on therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Triple antithrombotic therapy in cardiac patients: more questions than answers

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

5-Hydroxytryptamine3 receptor antagonists and cardiac side effects.

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Metoclopramide as a possible cause of prolonged QT syndrome and torsade de pointes in a patient with heart failure and renal insufficiency

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Challenges in using electronic health record data for CER: experience of 4 learning organizations and solutions applied

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Effect of measurement error on epidemiological studies of environmental and occupational exposures

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Identification of individuals with CKD from Medicare claims data: a validation study

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Dabigatran versus warfarin in the treatment of acute venous thromboembolism

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Oral rivaroxaban for symptomatic venous thromboembolism

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Catheter ablation for atrial fibrillation in patients with obesity.

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

21 January 2018

Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

7 January 2021

based on heuristic

inferred from DOI database lookup

Completeness of prescription recording in outpatient medical records from a health maintenance organization

1 reference

https://api.crossref.org/works/10.1002%2FCPT.359

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CPT.359

1 reference

Europe PubMed Central

PubMed publication ID

13 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30251866&oldid=1949505752"